My watch list  

IJMS, Vol. 19, Pages 1926: Adipose-Derived Mesenchymal Stem Cells: Are They a Good Therapeutic Strategy for Osteoarthritis?

IJMS, Vol. 19, Pages 1926: Adipose-Derived Mesenchymal Stem Cells: Are They a Good Therapeutic Strategy for Osteoarthritis?

International Journal of Molecular Sciences doi: 10.3390/ijms19071926

Authors: Elena Damia Deborah Chicharro Sergio Lopez Belen Cuervo Monica Rubio Joaquin J. Sopena Jose Manuel Vilar Jose Maria Carrillo

Osteoarthritis (OA) is a major cause of disability in elderly population around the world. More than one-third of people over 65 years old shows either clinical or radiological evidence of OA. There is no effective treatment for this degenerative disease, due to the limited capacity for spontaneous cartilage regeneration. Regarding the use of regenerative therapies, it has been reported that one option to restore degenerated cartilage are adipose-derived mesenchymal stem cells (ASCs). The purpose of this review is to describe and compare the efficacy of ASCs versus other therapies in OA. Methods: Recent studies have shown that ASCs exert paracrine effects protecting against degenerative changes in chondrocytes. According to the above, we have carried out a review of the literature using a combination of osteoarthritis, stem cells, and regenerative therapies as keywords. Results: Conventional pharmacological therapies for OA treatment are considered before the surgical option, however, they do not stop the progression of the disease. Moreover, total joint replacement is not recommended for patients under 55 years, and high tibia osteotomy (HTO) is a viable solution to address lower limb malalignment with concomitant OA, but some complications have been described. In recent years, the use of mesenchymal stem cells (MSCs) as a treatment strategy for OA is increasing considerably, thanks to their capacity to improve symptoms together with joint functionality and, therefore, the patients’ quality of life. Conclusions: ASC therapy has a positive effect on patients with OA, although there is limited evidence and little long-term follow-up.

Authors:   Damia, Elena ; Chicharro, Deborah ; Lopez, Sergio ; Cuervo, Belen ; Rubio, Monica ; Sopena, Joaquin J.; Vilar, Jose Manuel; Carrillo, Jose Maria
Journal:   International Journal of Molecular Sciences
Volume:   19
edition:   7
Year:   2018
Pages:   1926
DOI:   10.3390/ijms19071926
Publication date:   30-Jun-2018
Facts, background information, dossiers
  • mesenchymal stem cells
  • cartilage
  • Total
  • stem cells
  • solution
  • regenerative therapies
  • osteoarthritis
More about Molecular Diversity Preservation International
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE